ViaCyte Appoints Dr. Jon Wilensky as Head of Surgery

SAN DIEGO, July 21, 2021 /PRNewswire/ — ViaCyte, Inc., an innovator in cellular therapy and regenerative medicine, announced today that it has appointed Jon Wilensky, MD, MBA, FACS, as Head of Surgery. Dr. Wilensky will be responsible for training surgeons and advancing innovative…

No Comments

No comments yet.

Sorry, the comment form is closed at this time.